Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Oak Thistle LLC

Oak Thistle LLC increased its holdings in Amedisys, Inc. (NASDAQ:AMED) by 97.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,964 shares of the health services provider’s stock after acquiring an additional 3,440 shares during the quarter. Oak Thistle LLC’s holdings in Amedisys were worth $632,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AMED. Commonwealth Equity Services LLC boosted its stake in shares of Amedisys by 10.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider’s stock valued at $381,000 after buying an additional 409 shares during the last quarter. Parallel Advisors LLC boosted its stake in Amedisys by 28.9% during the 2nd quarter. Parallel Advisors LLC now owns 3,690 shares of the health services provider’s stock valued at $339,000 after acquiring an additional 827 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after acquiring an additional 19,660 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its position in shares of Amedisys by 12.9% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 5,421 shares of the health services provider’s stock worth $498,000 after purchasing an additional 619 shares during the last quarter. Finally, Highbridge Capital Management LLC raised its stake in shares of Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after purchasing an additional 83,200 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.1 %

NASDAQ:AMED opened at $91.86 on Thursday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of 36.45, a price-to-earnings-growth ratio of 1.84 and a beta of 0.72. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The stock has a 50-day simple moving average of $89.34 and a 200 day simple moving average of $94.44.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.98 EPS. Sell-side analysts predict that Amedisys, Inc. will post 4.45 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.